| ABT:Abbott Laboratories | | Charting | News | Options | |||||||||||||
| ||||||||||||||
| ||||||||||||||
| ||||||||||||||
1.13% $1.11
 Markets |
 Portfolio |
| |
| |
|
| |
|
|
|
|||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||
|
| Latest Story |
|
| Abbott introduces Ensure(R) Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop |
|
| PR Newswire |
|
-- New powder combines 30 grams of high--quality protein to help build muscle tissue,+ 5 grams of creatine monohydrate to support muscle recovery+* and 3 grams of calcium HMB (beta-hydroxy-beta-methylbutyrate) to help preserve muscle |
| Full Story → |
|
| Headline News |
|
| Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition |
| 9:00a ET October 5 '26 PR Newswire |
|
|
| Abbott hosts conference call for third-quarter earnings |
| 9:01a ET September 30 '26 PR Newswire |
|
|
| Abbott launches SimpleScreen(TM) CRC blood test, joining Cologuard Plus(R) in its colorectal cancer screening portfolio |
| 8:01a ET September 30 '26 PR Newswire |
|
| More News → |
| ||
|
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| October 9 '26. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Previous data from yesterday, October 8 '26. | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| Historical Price Performance | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Market data provided by 
News provided by   |
2.31%
